Development and qualification of a biomarker for preclinically identifying the pro-arrhythmia risk of drugs based on contractility measurements conducted in human adult primary cardiomyocytes
Ended Cooperative Agreement Awarded Last action
- Award ID
- U01FD006879
- Recipient
-
Anabios Corp UEI P3N4G7B5SRA7
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $247,461
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date
- Originally
- Funding agency
- Center for Drug Evaluation and Research Food and Drug Administration, Department of Health and Human Services
- Place of performance
- San Diego, CA 92109, USA
Award details come from USAspending.gov.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Original award | $247,461 |
Quick answers
Who received award U01FD006879?
U01FD006879 was awarded to Anabios Corp by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on September 1, 2019.
How much is award U01FD006879 worth?
$247,461 has been obligated on U01FD006879.
Which agency awarded U01FD006879?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U01FD006879, with funding from Center for Drug Evaluation and Research (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award